Therapeutic Implications of Immunogenic Cell Death in Human Cancer
Overview
Affiliations
Dendritic cells (DCs) are central to the adoptive immune response, and their function is regulated by diverse signals in a context-specific manner. Different DCs have been described in physiologic conditions, inflammation, and cancer, prompting a series of questions on how adoptive immune responses, or tolerance, develop against tumors. Increasing evidence suggests that tumor treatments induce a dramatic change on tumor-infiltrating lymphocytes and, in particular, on some DC subtypes. In this review, we summarize the latest evidence on the role of DCs in cancer and preliminary evidence on chemotherapy-associated antigens identified in human cancers.
Yao S, Han Y, Yang M, Jin K, Lan H Front Immunol. 2023; 14:1241208.
PMID: 37920463 PMC: 10619163. DOI: 10.3389/fimmu.2023.1241208.
Non-Oncologic Applications of Nanomedicine-Based Phototherapy.
Yoo S, Oh G, Ahn J, Chung E Biomedicines. 2021; 9(2).
PMID: 33504015 PMC: 7911939. DOI: 10.3390/biomedicines9020113.
Grimaldi A, Cammarata I, Martire C, Focaccetti C, Piconese S, Buccilli M Commun Biol. 2020; 3(1):85.
PMID: 32099064 PMC: 7042341. DOI: 10.1038/s42003-020-0811-x.
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology.
Vanmeerbeek I, Sprooten J, De Ruysscher D, Tejpar S, Vandenberghe P, Fucikova J Oncoimmunology. 2020; 9(1):1703449.
PMID: 32002302 PMC: 6959434. DOI: 10.1080/2162402X.2019.1703449.
Li W, Yang J, Luo L, Jiang M, Qin B, Yin H Nat Commun. 2019; 10(1):3349.
PMID: 31350406 PMC: 6659660. DOI: 10.1038/s41467-019-11269-8.